SynthesisFrontiers in nutrition2026
Nitric oxide precursor interventions for post-exercise delayed onset muscle soreness: a systematic review and network meta-analysis of randomized placebo-controlled trials.
Synthesis in Frontiers in nutrition, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Delayed onset muscle soreness (DOMS) commonly follows high-intensity or unaccustomed exercise. Nitric oxide (NO) precursors may reduce DOMS, but their effects remain uncertain. We conducted a systematic review and network meta-analysis to evaluate NO precursor interventions across recovery time points. Methods: PubMed, Embase, Web of Science, and CENTRAL were searched to February 2026 for randomized controlled trials in healthy adults. Interventions were classified into four nodes: beetroot-derived nitrate, watermelon-derived citrulline, synthetic or isolated amino acid precursors (L-arginine and citrulline malate), and watermelon plus added citrulline. Random-effects network meta-analyses were conducted separately at 24, 48, and 72 h. Effects were expressed as standardized mean differences (SMDs) with 95% confidence intervals (CIs); SUCRA rankings were exploratory. Risk of bias and evidence certainty were assessed using RoB 2 and CINeMA, with subgroup and sensitivity analyses examining robustness. Results: Nineteen trials involving 356 participants were included. At 24 h, watermelon plus added citrulline (SMD = -0.97, 95% CI -1.64 to -0.31) and beetroot-derived nitrate (SMD = -0.67, 95% CI -1.14 to -0.20) significantly reduced DOMS vs. placebo. At 48 h, beetroot-derived nitrate was the only intervention with a significant benefit (SMD = -1.18, 95% CI -1.91 to -0.45). No active intervention differed significantly from placebo at 72 h, while evidence for differences between active interventions was limited, with only watermelon plus added citrulline showing a significant advantage over synthetic or isolated amino acid precursors at 24 h. Beetroot-derived nitrate significantly reduced DOMS vs. placebo in the trained subgroup but not in the untrained subgroup. Sensitivity analyses generally supported the findings, although the beetroot-derived nitrate estimate was sensitive to some restrictions related to the exercise-induced muscle damage model. Conclusion: NO precursor supplementation may reduce post-exercise DOMS at specific recovery time points, particularly with beetroot-derived nitrate and watermelon plus added citrulline. However, evidence for differences between active interventions remains limited, and the sparse network, substantial heterogeneity, and low certainty of evidence preclude firm clinical conclusions. Systematic review registration: https://www.crd.york.ac.uk/PROSPERO/view/CRD420261373938, identifier: CRD420261373938.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.